LONG-TERM GLYCEMIC CONTROL AND THE RATE OF PROGRESSION OF EARLY DIABETIC KIDNEY-DISEASE

被引:79
作者
GILBERT, RE [1 ]
TSALAMANDRIS, C [1 ]
BACH, LA [1 ]
PANAGIOTOPOULOS, S [1 ]
OBRIEN, RC [1 ]
ALLEN, TJ [1 ]
GOODALL, I [1 ]
YOUNG, V [1 ]
SEEMAN, E [1 ]
MURRAY, RML [1 ]
COOPER, ME [1 ]
JERUMS, G [1 ]
机构
[1] AUSTIN HOSP,DEPT BIOCHEM,HEIDELBERG,VIC 3084,AUSTRALIA
关键词
D O I
10.1038/ki.1993.322
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In this prospective study of 11.9 years duration (range 9 to 14), we examined the progression of albuminuria prior to and after the onset of microalbuminuria [albumin excretion rate (AER): 20 to 200 mug/minute]. Glycated hemoglobin (HbA1), AER and blood pressure were measured every six months. Twenty-two (13 type I, 9 type II) patients were identified in whom AER increased progressively (progressors). These patients were compared with 22 others matched for age, duration and type of diabetes in whom AER did not change significantly during the study period (non-progressors). In the progressors, the rate of increase in AER correlated with mean HbA1 for the study period in patients with type I (r = 0.68, P < 0.01) and type II diabetes (r = 0.71, P < 0.05). Furthermore, AER began increasing well before the conventional 20 mug/minute threshold of microalbuminuria had been reached and within the first five years of diagnosis of type I diabetes. We conclude that in predisposed diabetic patients, long-term glycemic control is correlated with the rate of development of early renal abnormalities. Repeated measurements of AER from the time of diagnosis may be useful in the early detection of patients who will develop microalbuminuria and ultimately overt diabetic nephropathy.
引用
收藏
页码:855 / 859
页数:5
相关论文
共 35 条
[1]  
BORCHJOHNSEN K, 1988, KIDNEY HYPERTENSION, P33
[2]  
CHASE HP, 1991, CLIN CHEM, V37, P2048
[3]  
CHRISTENSEN CK, 1985, HYPERTENSION, V7, P109
[4]   REDUCTION OF URINARY ALBUMIN EXCRETION AFTER 4 YEARS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN INSULIN-DEPENDENT DIABETES-MELLITUS - THE OSLO STUDY [J].
DAHLJORGENSEN, K ;
HANSSEN, KF ;
KIERULF, P ;
BJORO, T ;
SANDVIK, L ;
AAGENAES, O .
ACTA ENDOCRINOLOGICA, 1988, 117 (01) :19-25
[5]   POSSIBLE GENETIC-DEFECTS IN REGULATION OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETIC NEPHROPATHY [J].
DECKERT, T ;
HOROWITZ, IM ;
KOFOEDENEVOLDSEN, A ;
KJELLEN, L ;
DECKERT, M ;
LYKKELUND, C ;
BURCHARTH, F .
DIABETES, 1991, 40 (06) :764-770
[6]  
DECKERT T, 1986, TRANSPLANT P, V18, P1636
[7]   THE KIDNEY IN MATURITY ONSET DIABETES-MELLITUS - A CLINICAL-STUDY OF 510 PATIENTS [J].
FABRE, J ;
BALANT, LP ;
DAYER, PG ;
FOX, HM ;
VERNET, AT .
KIDNEY INTERNATIONAL, 1982, 21 (05) :730-738
[8]  
FELDTRASMUSSEN B, 1986, LANCET, V2, P1300
[9]   EFFECT OF IMPROVED METABOLIC CONTROL ON LOSS OF KIDNEY-FUNCTION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS - AN UPDATE OF THE STENO STUDIES [J].
FELDTRASMUSSEN, B ;
MATHIESEN, ER ;
JENSEN, T ;
LAURITZEN, T ;
DECKERT, T .
DIABETOLOGIA, 1991, 34 (03) :164-170
[10]   INVITRO SYNTHESIS OF HEMOGLOBIN AIC [J].
FLUCKIGER, R ;
WINTERHALTER, KH .
FEBS LETTERS, 1976, 71 (02) :356-360